Shopping Cart
Remove All
Your shopping cart is currently empty
PCAF-IN-1 is a highly selective PCAF (p300/CBP-associated factor) inhibitor with potential anti-tumor, anti-inflammatory, and anti-heart disease effects. Inhibition of PCAF attenuates cardiac remodeling after myocardial infarction, reduces polarization of M1-type macrophages, and attenuates autoimmune arthritis.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $52 | - | In Stock | |
| 5 mg | $123 | - | In Stock | |
| 10 mg | $198 | - | In Stock | |
| 25 mg | $439 | - | In Stock | |
| 50 mg | $646 | - | In Stock | |
| 100 mg | $918 | - | In Stock | |
| 200 mg | $1,250 | - | In Stock |
| Description | PCAF-IN-1 is a highly selective PCAF (p300/CBP-associated factor) inhibitor with potential anti-tumor, anti-inflammatory, and anti-heart disease effects. Inhibition of PCAF attenuates cardiac remodeling after myocardial infarction, reduces polarization of M1-type macrophages, and attenuates autoimmune arthritis. |
| In vitro | Methods: Hepatocellular carcinoma (HePG-2), breast cancer (MCF-7), prostate cancer (PC3), and colorectal cancer (HCT-116) cells were treated with PCAF-IN-1 (10 μM, 72 hours), and cell viability was measured by MTT. Results: PCAF-IN-1 showed the strongest antitumor activity against human cancer cell lines. [1]. |
| Molecular Weight | 310.74 |
| Formula | C15H11ClN6 |
| Cas No. | 2439194-86-0 |
| Smiles | ClC=1C=CC(=CC1)C2=NN=C3C=4C=CC=CC4C(=NN)NN23 |
| Color | Gray |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: 0.1 mg/mL (0.32 mM), Sonication and heating are recommended. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.